Memory & Dementia
Memory loss does not always have just one cause. Alzheimer's disease, vascular brain injury, and other brain diseases can overlap. Understanding mixed dementia helps families make sense of symptoms and plan the next steps in care.
Written and medically reviewed by Amarish Dave, DO, board-certified neurologist. This page is educational and does not replace an individual medical evaluation.
Amarish Dave, DO — Board Certified Neurologist
Yes. A person can have brain changes from two or more dementia-causing diseases simultaneously. When multiple diseases contribute to cognitive impairment, this is called mixed dementia.
Dementia is a clinical syndrome, not one specific disease. It describes a decline in memory or other thinking abilities that interferes with everyday independence. Alzheimer's disease and dementia are not interchangeable terms: Alzheimer's is one possible cause of dementia.
The most common combination is Alzheimer's disease plus vascular dementia. Alzheimer's disease involves abnormal amyloid and tau proteins. Vascular brain injury involves damage associated with blood vessels and blood flow, including strokes and small-vessel disease. Both processes can contribute to cognitive decline.
Other combinations include Alzheimer's disease with Lewy body disease, all three together, or other overlapping neurodegenerative conditions. Lewy bodies contain abnormal accumulations of a protein called alpha-synuclein. The symptoms reflect the combined effects of these brain changes, not necessarily two clearly separate sets of symptoms.
Mixed brain pathology is particularly common in older adults. According to the Alzheimer's Association's 2026 Alzheimer's Disease Facts and Figures report, more than 50% of people diagnosed with Alzheimer's dementia studied at Alzheimer's Disease Research Centers had mixed dementia.
This finding comes from selected research populations and should not be interpreted as the prevalence among all people with dementia. Studies that examine brain tissue after death help reveal overlapping changes that may not have been recognized during life. The exact proportion depends on the population and how the diseases are identified.
Symptoms depend on the diseases involved, the brain regions affected, and the extent of injury. They may include:
No single symptom proves mixed dementia. Changes in function and observations from someone who knows the person well are important parts of the assessment.
Sudden weakness, facial drooping, speech difficulty, or abrupt confusion may signal a stroke or another emergency. Call 911 rather than assuming a sudden change is dementia progression.
A memory loss evaluation starts with a detailed neurological history, including symptom timing, daily function, vascular risk factors, and family observations. The evaluation may include:
MoCA and SLUMS are screening tools, not stand-alone diagnoses. Similarly, MRI findings alone do not establish mixed dementia: vascular changes on a scan do not necessarily explain a person's symptoms.
Alzheimer's blood tests and other biomarkers can help selected patients, but results require clinical interpretation. Identifying every contributing pathology during life can be difficult; a working diagnosis may change as more information becomes available. Read more about dementia diagnosis and evaluation.
Management depends on the underlying causes and the person's health and goals. There is no FDA-approved medication specifically for mixed dementia. However, treating symptoms and contributing conditions can still be valuable.
Alzheimer's medications may be appropriate when Alzheimer's disease contributes. Cholinesterase inhibitors or memantine may help selected patients. Anti-amyloid treatment requires an individualized specialist assessment; having mixed dementia does not automatically make someone eligible, and vascular injury may affect safety and suitability.
Do not start or stop medicines without medical advice. A personalized dementia treatment plan balances possible benefits, side effects, and practical needs.
Recognizing more than one contributing condition can influence medication choices, vascular risk reduction, and expectations about symptoms. It can also guide caregiver planning for mobility, medication supervision, driving, finances, and living arrangements.
The label does not predict an individual's rate of decline. Follow-up focuses on actual changes in thinking and daily function, what remains treatable, and the support the person and family need.
Memory & Dementia
Amarish Dave, DO, Board-Certified Neurologist, compares the MoCA and SLUMS memory tests — how each is scored, how long each takes, and what an abnormal result does and does not mean.
Watch Video
Memory & Dementia
Amarish Dave, DO, Board-Certified Neurologist, explains how families can tell when someone with dementia is no longer safe living alone.
Watch Video
Memory & Dementia
Amarish Dave, DO explains the stages of dementia—the 7-stage framework, early, middle and late dementia, and why progression varies from person to person.
Watch Video
Memory & Dementia
Amarish Dave, DO explains sundowning—increased confusion, agitation and restlessness late in the day in people with dementia—and what caregivers can do.
Watch VideoThe information on this website is educational and does not replace an individual medical evaluation. It does not diagnose any condition. If you believe you are experiencing a medical emergency, call 911.
NeurologistCare provides neurological evaluations for memory loss, Alzheimer's disease, mixed dementia, and other cognitive disorders. Serving Crystal Lake, Woodstock, and Lake Geneva, with telehealth options for eligible patients physically located in Illinois or Wisconsin at appointment time.
Schedule a Neurology EvaluationChoose the scheduling line for the state where you will be located for your appointment.
Available at three office locations:
Crystal Lake, Illinois
Woodstock, Illinois
Lake Geneva, Wisconsin
Telehealth neurology appointments are available to patients located anywhere in Illinois or Wisconsin. You do not need to live near an office, but you must be physically located in Illinois or Wisconsin at the time of the appointment.
Learn about telehealth neurology →Illinois appointments: 815-337-7100. Wisconsin appointments: 262-245-0535.
Our office will confirm whether an in-person or telehealth visit is appropriate and provide the details.
Insurance participation and referral requirements vary by plan. Our office will confirm what your plan requires before your visit.
If you believe you are experiencing a medical emergency, call 911 or seek emergency medical attention.